Ezetimibe,bempedoic acid
esperion
[]
in the acc presentation and press conference on $espr's nexletol, steven nissen has mentioned repeatedly that when combined with ezetimibe the ldl lowering is 35%-40%, on par with a medium intensity statin. #acc23
Writing and events at STAT. This is biology's century; Every data point has a face. ‘21 Polk Award.

Mastodon: @matthewherper@federate.social